New inhaled nausea drug shows promise in early trial
NCT ID NCT07498751
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested an inhaled powder form of ondansetron, a common nausea medicine, in 24 healthy adults. The goal was to see if the drug gets into the blood through the lungs and to check for any side effects. Participants received either the inhaled drug, a placebo, or the standard pill or injection for comparison.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE NAUSEA AND VOMITING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Altasciences Clinical Research Unit
Mount Royal, Quebec, H3P 3P1, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple anesthetic choice prevent Post-Surgery vomiting?
- Deep breaths may slash post-surgery pain and anxiety — a trial puts it to the test
- Scientists investigate hidden triggers of Post-Surgery nausea
- New pain drug may cut Post-Surgery nausea
- Which drug combo best stops Post-Surgery sickness?
- Can a tote bag replace pills? new study tests comfort kit for teens after scoliosis surgery